Gordon Gibb is a writer, broadcaster and media specialist who has contributed to LawyersandSettlements.com since 2007. His specialty is getting to the heart of an issue quickly, and complex subjects are more easily understood in his hands. His work has appeared in major international magazines and newspapers, and his two books on Nobel Peace Prize winner Lester B. Pearson were published in 2006 and 2015 respectively. A book of essays and newspaper columns entitled ‘Gibberish: Tall Tales and Domestic Disasters from Beyond the Microphone’ was released in 2014. A novel, ‘The Fifth Season,’ is due in 2016. When not writing and producing his daily radio program, Gordon operates a voiceover studio at www.GordonGibb.com and runs an oldies music channel at www.yourKawarthaOLDIES.com.Follow Gordon on
February 22, 2017.
Bergen, NJ: It was back in 2008 that Hip Replacement Implant Failure caught up with Zimmer, when its Alumina Ceramic Femoral Head component was subject to a Class 2 recall by the US Food and Drug Administration (FDA). According to the official recall posting, Zimmer stated the reason for the recall: “When used with cobalt/chromium hip stems, the average test values for ceramic head bursting falls below the guidance document limits if the taper is made by casting instead of by forging.”Read [ The FDA Shortcut to a Hip Replacement Lawsuit ]
February 21, 2017.
Philadelphia, PA: With Risperdal side effects lawsuits continuing to grow at a compelling rate within a mass tort in the Philadelphia Court of Common Pleas, the file is poised to move forward with a meeting planned for March 9 with regard to the centralized litigation (In Re: Risperdal Litigation, Case No. 100300296).Read [ Risperdal Case Load Shows No Sign of Slowing Down ]
February 21, 2017.
Washington, DC: In a blog posted to the official website of the US Food and Drug Administration (FDA) in October of last year, the regulator’s Director of the Center for Devices and Radiological Health noted that a survey conducted the year prior involving hospitals demonstrated that numerous reports of Ovarian cancer cells spread by power morcellators were not shared with the FDA’s adverse reporting system. An accompanying inspection found that in many cases hospitals had no system in place for staff to submit reports to the FDA or device makers; and that staff did not always know, or were not properly trained with regard to the reporting of injuries and deaths associated with medical devices.Read [ Regulatory Concern Mounting Over Power Morcellators, Adverse Events Reports ]
February 20, 2017.
Los Angeles, CA: A former sports commentator with ESPN known for his knowledge of tennis launched a wrongful termination lawsuit in a California court against his former employer the day before Valentine’s Day this year. At issue is an on-air comment Doug Adler is alleged to have uttered during coverage of the 2017 Australian Open and, in particular use of a word the plaintiff asserts he did not use.Read [ Former ESPN Commentator Sues for Wrongful Termination ]
February 19, 2017.
Washington, DC: Any patient about to be implanted with an IVC filter, or presented with a recommendation for same by their doctor, would naturally assume the procedure is necessary and unavoidable. Indeed, for many patients who can’t tolerate blood thinners the placement of this medical catcher’s mitt remains a life-sustaining strike against the potential catastrophe of a wayward blood clot.Read [ Blogger Says ‘No Thanks’ to IVC Filter ]
February 19, 2017.
Concord, NH: He may have the same name as the long-dead soul singer, but James Brown does not feel good about the C-Qur abdominal mesh used for a hernia repair and the plaintiff, through his surgical mesh lawsuit, has plenty to say about it.Read [ Plaintiff Claims C-Qur Mesh Biologically Incompatible with Human Tissue ]
February 17, 2017.
Boston, MA: The INRatio measuring system manufactured by Alere Inc. (Alere) and subject to an Alere recall last year, has oft been highlighted as part of a study focused on the effectiveness of a new-generation blood thinner when compared against warfarin. The oft-made allegation is that inaccurate readings may have given the newer anticoagulant, in this case Xarelto, an unfair advantage over Coumadin (warfarin). The US Food and Drug Administration (FDA) has since opined that in its view, the variances in readings were not drastic enough to sufficiently skew the results.Read [ Alere INRatio Plaintiffs Petition Court to Keep Lawsuit Alive ]
February 16, 2017.
San Francisco, CA: A somewhat unique wage and hour lawsuit that stemmed from what appeared to be an attempt at bartering is winding down with the preliminary approval of a settlement worth $1.65 million. The defendant, CorePower Yoga, denied any wrongdoing in the matter. A fairness hearing is scheduled for June, to determine whether final approval is warranted in the California wage and hour settlement.Read [ Preliminary Settlement Reached Quickly in California Wage and Hour Dispute ]
February 15, 2017.
New Orleans, LA: The 800 lawsuits currently enshrouded in Taxotere hair loss multidistrict litigation are moving forward by way of updated orders and directives issued February 1 by the US District Court for the Eastern District of Louisiana. Plaintiffs assert that Taxotere, a chemotherapy drug, triggered Taxotere alopecia (hair loss) that has been characterized as permanent.Read [ Taxotere Hair Loss Lawsuits Moving Forward in MDL ]
February 15, 2017.
Kenilworth, NJ: Her name is Lexi and she’s a young mother with a five-month-old baby who recounts in a YouTube video what turned out to be a horrid experience with Nexplanon birth control. Nexplanon, an implantable birth control device, is essentially the same product as Implanon birth control, only with the addition of barium sulfate to aid in locating the device for removal once the birth control device is depleted, usually after the third year.Read [ Young Mother Recounts Horrid Experience with Birth Control Implant ]